Seage G R, Landers S, Mayer K H, Barry M A, Lamb G A, Epstein A M
Community Infectious Disease Epidemiology Program, Boston Department of Health and Hospitals, MA 02118.
Am J Public Health. 1988 Aug;78(8):969-70. doi: 10.2105/ajph.78.8.969.
A cost-of-illness study July 1, 1984-June 30, 1985 evaluating 28 patients with AIDS-Related Complex (ARC) and/or Generalized Lymphadenopathy Syndrome (GLS) found the average cost to be $489 per patient per year. None of the ARC or GLS patients in our study was hospitalized during the one year period, and none progressed to AIDS. No AIDS-specific treatment such as AZT was available at the time this study was completed.
一项在1984年7月1日至1985年6月30日期间开展的疾病成本研究,对28例患艾滋病相关综合征(ARC)和/或全身性淋巴结病综合征(GLS)的患者进行评估,结果发现每位患者每年的平均成本为489美元。在我们的研究中,ARC或GLS患者在这一年期间均未住院,且无一人病情进展为艾滋病。在本研究完成时,尚无齐多夫定(AZT)等艾滋病特异性治疗方法。